Suchergebnisse - "Beare, Sandy"

PubPharm (29)

21

Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

enthalten in: The lancet / Oncology | 2017

von Glynne-Jones, R. | Sebag-Montefiore, D. | Meadows, H. | +9

22

Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

enthalten in: The lancet / Oncology | 2017

von Glynne-Jones, R. | Sebag-Montefiore, D. | Meadows, H. | +9

23

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03) : a randomised phase 2 trial

enthalten in: The Lancet. Oncology | 2015

von Valle, J. | Wasan, H. | Lopes, A. | +16

CommentIn: Lancet Oncol. 2015 Aug;16(8):882-3. - PMID 26179202

24

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

enthalten in: The lancet / Oncology | 2015

von Valle, J. | Wasan, H. | Lopes, A. | +16

25

Capturing data on colostomy formation in anal cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Glynne-Jones, R. | Beare, S. | Begum, R. | +1

CommentOn: J Clin Oncol. 2012 Jun 1;30(16):1941-8. - PMID 22529257

26

Capturing Data on Colostomy Formation in Anal Cancer

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2013

von Glynne-Jones, R. | Beare, S. | Begum, R. | +1

27

Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer

enthalten in: The New England journal of medicine | 2012

von Mallick, U. | Harmer, C. | Yap, B. | +25

CommentIn: N Engl J Med. 2012 May 3;366(18):1732-3. - PMID 22551133

28

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

enthalten in: The New England journal of medicine | 2012

von Mallick, U. | Harmer, C. | Yap, B. | +25

29

Iodine or Not (IoN) for low-risk differentiated thyroid cancer : the next UK National Cancer Research Network randomised trial following HiLo

enthalten in: Clinical oncology (Royal College of Radiologists (Great Britain)) | 2012

von Mallick, U. | Harmer, C. | Hackshaw, A. | +25